Millions of Americans suffer from undiagnosed pain, often stemming from joint issues or neuropathy. NexGenEsis Healthcare is at the forefront of helping these individuals heal through cutting-edge ...

Two new medications, called lecanemab and donanemab, have shown success in clinical trials in slowing down Alzheimer’s disease. These are known as disease-modifying treatments and have been licensed ...